Journal of Glaucoma

Response to Letter to the Editor: Cost Utility of Schlemm Canal Microstent Injection With Cataract Surgery for Open Angle Glaucoma in the US Medicare System.  32:E2. 2023

Frequency of Optical Coherence Tomography Testing to Detect Progression in Glaucoma.  31:854-859. 2022

Smoking Cessation May Reduce Risk of Visual Field Progression in Heavy Smokers.  31:796-803. 2022

Cost Utility of Schlemm's Canal Microstent Injection with Cataract Surgery for Open Angle Glaucoma in the United States Medicare System 2022

Detecting Progression in Patients with Different Clinical Presentations of Primary Open-Angle Glaucoma.  30:769-775. 2021

Alabama Screening and Intervention for Glaucoma and Eye Health through Telemedicine (AL-SIGHT): Study Design and Methodology.  30:371-379. 2021

Disc Hemorrhages Are Associated with the Presence and Progression of Glaucomatous Central Visual Field Defects.  29:429-434. 2020

The Relationship between Intraocular Pressure and Rates of Central Versus Peripheral Visual Field Progression.  29:435-440. 2020

Bacteroides Spp. Blebitis, Keratitis, and Endophthalmitis Following Uncomplicated Trabeculectomy.  28:e118-e120. 2019

Glaucoma Patient Knowledge, Perceptions, and Predispositions for Telemedicine.  28:481-486. 2019

Compliance with primary open-angle glaucoma and primary open-angle glaucoma suspect preferred practice patterns in a retail-based eye clinic.  27:1068-1072. 2018

Prediction accuracy of the dynamic structure-function model for glaucoma progression using contrast sensitivity perimetry and confocal scanning laser ophthalmoscopy.  27:785-793. 2018

Differences in ocular blood flow between people of African and European descent with healthy eyes.  25:709-715. 2016

Binocular visual field impairment in glaucoma and at-fault motor vehicle collisions.  24:138-143. 2015

Differences in ocular blood flow in glaucoma between patients of African and European descent.  24:117-121. 2015

Outcomes of shunt tube coverage with glycerol preserved cornea versus pericardium.  23:258-261. 2014

African descent and glaucoma evaluation study: Asymmetry of structural measures in normal participants.  22:65-72. 2013

Comparison of visual field severity classification systems for glaucoma.  21:551-561. 2012

Determinants of medication adherence to topical glaucoma therapy.  21:234-240. 2012

Circumferential trabeculotomy with an illuminated microcatheter in congenital glaucomas.  21:160-163. 2012

In response.  19:279-280. 2010

Combining functional and structural tests improves the diagnostic accuracy of relevance vector machine classifiers.  19:167-175. 2010

The association between self-reported glaucoma and Ginkgo biloba use.  18:543-545. 2009

Artifacts on the optic nerve head analysis of the optical coherence tomography in glaucomatous and nonglaucomatous eyes.  18:186-191. 2009

Discussion.  17:592-593. 2008

Progressive normal-tension glaucoma.  17:591. 2008

Premise and prediction-how optic nerve head biomechanics underlies the susceptibility and clinical behavior of the aged optic nerve head.  17:318-328. 2008

The impact of the perimetric measurement scale, sample composition, and statistical method on the structure-function relationship in glaucoma.  16:676-684. 2007

Visual field defects and vision-specific health-related quality of life in African Americans and Whites with glaucoma.  15:414-418. 2006

Agreement in assessing cup-to-disc ratio measurement among stereoscopic optic nerve head photographs, HRT II, and Stratus OCT.  15:183-189. 2006

Glaucoma after ocular contusion: A cohort study of the United States Eye Injury Registry.  14:470-473. 2005

Curbing our enthusiasm.  14:329-330. 2005

Memantine and Progressive Glaucoma.  14:84-86. 2005

Possible mechanisms responsible for elevated IOP in POAG patients..  12. 2003

Thin corneas and the risk of progression..  12:445-446. 2003

Intraocular pressure in a Somali population living in the United States.  12:365-369. 2003

Letter to the editor [1] (multiple letters).  12:445. 2003

Thin corneas and the risk of progression [2] (multiple letters).  12:445-446. 2003

Management of iris melanoma with secondary glaucoma.  11:71-74. 2002

The role of neuroimaging studies in normal-pressure glaucoma.  11:277-278. 2002

Strategies for neuroprotection.  10:S78-S80. 2001

Strategies for neuroprotection..  10:S78-S80. 2001

Strategies for neuroprotection.  10. 2001

Neovascular glaucoma and ocular ischemic syndrome.  9:409-412. 2000

Central nervous system and plasma lipid profiles associated with carteolol and timolol in postmenopausal black women.  8:388-395. 1999